Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877862 · ClinicalTrials.gov registry record · NA
Mobile Phone Technology to Increase Genetic Counseling
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT02877862: Completed NA study, sponsored by University of Minnesota.
NCT02877862 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877862, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
This innovative project seeks to harness mobile phone technology as a means to take preventive health care to a new level among ovarian cancer survivors. Using the Fogg Behavioral Model, developed from the concept of persuasive technology, this study proposes to develop the Mobile Application for Genetic Information on Cancer (mAGIC) intervention to motivate ovarian cancer survivors to undergo genetic counseling. The overall study objective is to develop and assess the feasibility and effectiveness of a theory-based intervention aimed to encourage ovarian cancer survivors to receive genetic counseling
Primary Outcome
Report of attendance of an appointment with genetic counselor to discuss cancer genetics related to ovarian cancer diagnosis
Interventions
- BEHAVIORAL mAGIC app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-02 |
| Phase | NA |
What the finished NCT02877862 record still lists
NCT02877862 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which mAGIC app is the first listed.
NCT02877862 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02877862 about?
NCT02877862 is a clinical study titled "Mobile Phone Technology to Increase Genetic Counseling". This innovative project seeks to harness mobile phone technology as a means to take preventive health care to a new level among ovarian cancer survivors. Using the Fogg Behavioral Model, developed from the concept of persuasive technology, this study proposes to develop the Mobile Application for Ge...
What is the current status of trial NCT02877862?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2016-02. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02877862?
The interventions under investigation include: mAGIC app (BEHAVIORAL).
Who is sponsoring clinical trial NCT02877862?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02877862's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia